What are Catalyst Pharmaceutical's profit margins?

Gross margin is 86.0% and operating margin is 44.8%, with a 37.1% net margin.

Where does Catalyst Pharmaceutical's income statement data come from?

Every line is extracted from Catalyst Pharmaceutical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Catalyst Pharmaceutical CPRX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$596.96M+1.4%	$588.99M+1.9%	$578.2M+3.5%	$558.5M+4.5%	$534.65M+8.7%
Total cost of revenue	$83.82M-3.9%	$87.25M+5.4%	$82.82M+4.3%	$79.45M+7.0%	$74.24M+7.8%
Gross profit	$513.14M+2.3%	$501.74M+1.3%	$495.37M+3.4%	$479.05M+4.0%	$460.41M+8.9%
Gross margin	86%+0.8pp	85.2%-0.5pp	85.7%-0.1pp	85.8%-0.3pp	86.1%+0.1pp
Research and development	$11.48M-9.6%	$12.71M-13.5%	$14.7M-4.1%	$15.33M+9.8%	$13.95M+10.3%
Selling, general and administrative	$196.16M+1.2%	$193.75M+5.0%	$184.52M+0.9%	$182.93M+2.9%	$177.71M0.0%
Operating income	$267.64M+3.8%	$257.78M-0.4%	$258.78M+6.3%	$243.42M+5.2%	$231.37M+18.6%
Operating margin	44.8%+1.1pp	43.8%-1.0pp	44.8%+1.2pp	43.6%+0.3pp	43.3%+3.6pp
Other income (expense), net	$28.82M+12.0%	$25.74M-4.7%	$27.02M-5.4%	$28.55M+5.4%	$27.1M+28.2%
Income before income taxes	$296.46M+4.6%	$283.52M-0.8%	$285.8M+5.1%	$271.97M+5.2%	$258.46M+19.5%
Income tax expense	$75.14M+8.6%	$69.19M+1.4%	$68.23M+7.8%	$63.3M+3.6%	$61.11M+16.7%
Net income	$221.32M+3.3%	$214.33M-1.5%	$217.56M+4.3%	$208.67M+5.7%	$197.35M+20.4%
Net margin	37.1%+0.7pp	36.4%-1.2pp	37.6%+0.3pp	37.4%+0.4pp	36.9%+3.6pp
Diluted earnings per share	$1.74+3.0%	$1.69-1.7%	$1.72+4.2%	$1.65+5.1%	$1.57+19.8%
Basic earnings per share	$1.81+2.8%	$1.76-1.7%	$1.79+3.5%	$1.73+4.8%	$1.65+19.6%
Weighted-average shares, diluted	508.8M0.0%	508.8M+0.5%	506.5M+0.3%	504.9M+0.6%	502M+0.7%
Weighted-average shares, basic	489.3M+0.2%	488.5M+0.8%	484.7M+0.8%	481M+0.8%	477M+1.0%
Amortization Expenses Of Intangible Asset	$37.86M+1.0%	$37.5M+0.3%	$37.38M0.0%	$37.38M0.0%	$37.38M0.0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$221.35M+3.3%	$214.26M-1.5%	$217.56M+4.2%	$208.7M+5.8%	$197.33M+20.4%
Operating Expense	$329.32M-0.6%	$331.21M+3.7%	$319.42M+1.4%	$315.08M+3.9%	$303.28M+2.2%
Net unrealized gains (losses) on securities still held	$25K+139%	-$64K—	$0-100%	$31K+282%	-$17K-134%
Other income, net (Note 6)	$28.82M+12.0%	$25.74M-4.7%	$27.02M-5.4%	$28.55M+5.4%	$27.1M+28.2%
Revenue From Contract With Customer Excluding Assessed Tax	$596.96M+1.4%	$588.99M+1.9%	$578.2M+3.5%	$558.5M+4.5%	$534.65M+8.7%
EBIT	$267.64M+3.8%	$257.78M-0.4%	$258.78M+6.3%	$243.42M+5.2%	$231.37M+18.6%
EBITDA	$305.83M+3.4%	$295.65M-0.3%	$296.57M+5.4%	$281.25M+4.5%	$269.17M+15.6%
EBITDA	$305.83M+3.4%	$295.65M-0.3%	$296.57M+5.4%	$281.25M+4.5%	$269.17M+15.6%
EBITDA margin	51.2%+1.0pp	50.2%-1.1pp	51.3%+0.9pp	50.4%0.0pp	50.3%+3.0pp
EBIT	$267.64M+3.8%	$257.78M-0.4%	$258.78M+6.3%	$243.42M+5.2%	$231.37M+18.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Catalyst Pharmaceutical's profit margins?: Gross margin is 86.0% and operating margin is 44.8%, with a 37.1% net margin.
Where does Catalyst Pharmaceutical's income statement data come from?: Every line is extracted from Catalyst Pharmaceutical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.